Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.
Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.
This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).
NOTE: This test is only for internal use only. It is active in the Lab System only – and will need to be manually entered via LOM if needed.
PD-L1, PDL1, 22C3, KEYTRUDA, pembrolizumab, IHC, Immunohistochemistry
blood pH, arterial pH
blood pH, venous pH
+3/+7+9/+1513q- / -13 (13q deletion) or RB117p- (17p deletion) or TP53-13 (monosomy 13)IGH (14q32) rearrangementMonoclonal Gammopathy of Unknown Significance (MGUS)Multiple MyelomaMYC (8q24.1) rearrangementPlasma Cell Leukemiat(4;14) - FGFR3/IGHt(6;14) - CCND3/IGHt(11;14) - CCND1/IGHt(14;16) - IGH/MAFt(14;20) - IGH/MAFB+1q or 1q22
PAI-1 Ag, P
PLM, PLM6S, Platelet Mapping ADP, Platelet Mapping AA
HKH-MA, ActFMA, ADP-MA, %INH-ADP, %AGG-ADP, AA-MA, %INH-AA, %AGG-AA
Acute Intermittent Porphyria (AIP) Hereditary Coproporphyria (HCP) PBG (Porphobilinogen) Variegate Porphyria (VP)
Special Note: Patient must be off of Coumadin for three weeks to order this test as Coumadin will lower Protein C Antigen level. If on Coumadin, order PROT-CM.
Protein C Immunologic